Literature DB >> 20972890

Triggering of the antibacterial activity of Bacillus subtilis B38 strain against methicillin-resistant Staphylococcus aureus.

Olfa Tabbene1, Ines Karkouch, Imen Ben Slimene, Najib Elfeddy, Pascal Cosette, Maria-Luisa Mangoni, Thierry Jouenne, Ferid Limam.   

Abstract

When cultured in minimal growth medium, the B38 strain of Bacillus subtilis did not exhibit any antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) clinical isolate. Coculturing B38 strain with viable MRSA cells weakly increased antibacterial activity production (20 AU/ml). Addition of dead MRSA cells in a B38 culture, increased by 8-fold the B. subtilis strain antibacterial activity reaching 160 AU/ml against MRSA strain. This antibacterial activity recovered from cell-free supernatants was stimulated by an autoinducing compound which is sensitive to the action of proteinase K suggesting a proteinaceous nature. This compound was heat-stable till 80 °C and showed a molecular mass around 20 kDa as determined by SDS-PAGE. These results suggest that the production of antibacterial compounds by B38 strain is dependent on the amount of the autoinducing compound.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972890     DOI: 10.1007/s12010-010-9112-z

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  2 in total

1.  Antimicrobial activities of Bacillus velezensis strains isolated from stingless bee products against methicillin-resistant Staphylococcus aureus.

Authors:  Mohamad Malik Al-Adil Baharudin; Mohamad Syazwan Ngalimat; Fairolniza Mohd Shariff; Zetty Norhana Balia Yusof; Murni Karim; Syarul Nataqain Baharum; Suriana Sabri
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

2.  Induction of resistance to S. aureus in an environmental marine biofilm grown in Sydney Harbor, NSW, Australia.

Authors:  John E Lafleur; Scott A Rice
Journal:  World J Microbiol Biotechnol       Date:  2014-12-20       Impact factor: 3.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.